{"date":"2026-08-20","count":14,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6949-2026-08-20-2237-1lsubmy","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-08-20","time":"22:37:46","subject":"公告本公司「NKp30(ISOLATED NUCLEIC ACID MOLECULECOMPRISING NKP30 TRANSMEMBRANE DOMAIN AND CHIMERIC ANTIGENRECEPTOR COMPRISING THE SAME)」多鏈CAR-T技術取得日本專利","clause":"第51款","fact_date":"2026-08-20","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-08-20 22:37，「公告本公司「NKp30(ISOLATED NUCLEIC ACID MOLECULECOMPRISING NKP30 T」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-08-20-1810-16xx3hr","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-08-20","time":"18:10:50","subject":"代子公司嘉文麗（福建）化妝品限公司公告累積取得或處分理財產品","clause":"第20款","fact_date":"2026-08-20","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-08-20 18:10，「代子公司嘉文麗（福建）化妝品限公司公告累積取得或處分理財產品」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-08-20-1809-udix35","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-08-20","time":"18:09:01","subject":"公告本公司董事會決議補行委任第四屆薪資報酬委員會委員","clause":"第6款","fact_date":"2026-08-20","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-08-20 18:09，「公告本公司董事會決議補行委任第四屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-08-20-1808-37n2dy","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-08-20","time":"18:08:40","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-20","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-08-20 18:08，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-08-20-1808-1egfkms","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-08-20","time":"18:08:16","subject":"公告本公司董事會通過重要決議","clause":"第51款","fact_date":"2026-08-20","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-08-20 18:08，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2026-08-20-1710-difvce","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2026-08-20","time":"17:10:38","subject":"公告本公司代理發言人任命案","clause":"第11款","fact_date":"2026-08-20","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2026-08-20 17:10，「公告本公司代理發言人任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2026-08-20-1709-1u44rs5","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2026-08-20","time":"17:09:14","subject":"公告本公司財務主管任命案","clause":"第11款","fact_date":"2026-08-20","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2026-08-20 17:09，「公告本公司財務主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-08-20-1703-6w639w","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-08-20","time":"17:03:06","subject":"本公司115年8月31日受邀參加元大證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-08-31","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-08-20 17:03，「本公司115年8月31日受邀參加元大證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2026-08-20-1700-190fsk7","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-08-20","time":"17:00:42","subject":"本公司受邀參加永豐金證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-08-25","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-08-20 17:00，「本公司受邀參加永豐金證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-08-20-1601-3xt13e","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-08-20","time":"16:01:16","subject":"本公司受邀參加華南永昌綜合證券舉辦之秋季產業趨勢暨企業論壇","clause":"第12款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-08-20 16:01，「本公司受邀參加華南永昌綜合證券舉辦之秋季產業趨勢暨企業論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-08-20-1547-11bqfz8","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-08-20","time":"15:47:33","subject":"代子公司馬光國際依公開發行公司資金貸與及背書保證處理準則第22條第1項第3款公告","clause":"第23款","fact_date":"2026-08-20","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-08-20 15:47，「代子公司馬光國際依公開發行公司資金貸與及背書保證處理準則第22條第1項第3款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-08-20-1547-1nuv64a","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-08-20","time":"15:47:14","subject":"公告本公司董事會通過115年第二季合併財務報告案","clause":"第31款","fact_date":"2026-08-20","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-08-20 15:47，「公告本公司董事會通過115年第二季合併財務報告案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2026-08-20-1501-1we32s4","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2026-08-20","time":"15:01:04","subject":"公告本公司董事會通過115年第二季度合併財務報告","clause":"第31款","fact_date":"2026-08-20","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2026-08-20 15:01，「公告本公司董事會通過115年第二季度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-08-20-1432-1bzb5nj","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-08-20","time":"14:32:39","subject":"公告本公司私募普通股收足股款暨調整增資基準日。","clause":"第53款","fact_date":"2026-08-20","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-08-20 14:32，「公告本公司私募普通股收足股款暨調整增資基準日。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}